Ann: Afamelanotide well tolerated by first stroke patients, page-4

I'd like to see some imaging pics before and after. It's a good start. It's always been a focus to ensure safety and the fact that it's been well tolerated in all cases is a posiitve going forward. If it's had a good effect on 2 out of three (one very good?), then the future looks bright- I'd take it if given a 66% chance of less damage. Early days but very positive start IMO. There's lots of subjects out there so the trial should progress well from here. Interested to see the progression to phase three and how they tackle it eventually. GLTA